SynCardia Freedom Driver System Study

This study is currently recruiting participants.
Verified June 2012 by SynCardia Systems. Inc.
Sponsor:
Information provided by (Responsible Party):
SynCardia Systems. Inc.
ClinicalTrials.gov Identifier:
NCT00733447
First received: August 11, 2008
Last updated: June 8, 2012
Last verified: June 2012

August 11, 2008
June 8, 2012
March 2010
September 2013   (final data collection date for primary outcome measure)
Freedom Driver is a suitable pneumatic driver for clinically stable TAH-t subjects. [ Time Frame: Transplant, 90 days or death ] [ Designated as safety issue: Yes ]
Transplant, 90 days of support from date of discharge, 90 days of in-hospital support for subjects who are not discharged, or death
Companion Driver is a suitable replacement for the CSS Console. [ Time Frame: Transplant, 180 days or death ] [ Designated as safety issue: Yes ]
Complete list of historical versions of study NCT00733447 on ClinicalTrials.gov Archive Site
Freedom Driver can be safely used at home. [ Time Frame: Transplant, 90 days or death ] [ Designated as safety issue: Yes ]
Transplant, 90 days of support from date of discharge, 90 days of in-hospital support for subjects who are not discharged, or death
Companion Driver can be safely used at home. [ Time Frame: Transplant, 180 days or death ] [ Designated as safety issue: Yes ]
Not Provided
Not Provided
 
SynCardia Freedom Driver System Study
SynCardia Freedom Driver System Study

The purposes of this study are to confirm that the Freedom Driver System is a suitable pneumatic driver for clinically stable TAH-t subjects, and that patients and lay caregivers can be trained to manage the Freedom Driver System safely outside the hospital.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Biventricular Failure
Device: CardioWest temporary Total Artificial Heart (TAH-t) System
The SynCardia CardioWest temporary Total Artificial Heart (TAH-t) System is a pulsatile biventricular device that replaces a patient's native ventricles and valves, and pumps blood to both pulmonary and systemic circulation. The system consists of the implantable CardioWest TAH-t and an external pneumatic driver connected by drivelines.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
Not Provided
September 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients who are implanted with the TAH-t and are clinically stable.

Exclusion Criteria:

  • Patients who are implanted with the TAH-t and are not clinically stable.
Both
Not Provided
No
Contact: Michael Garippa 520 618-1853 mgarippa@syncardia.com
Contact: Judith Skroback 520 547-7466 jskroback@syncardia.com
United States
 
NCT00733447
RA-142, P030011
Yes
SynCardia Systems. Inc.
SynCardia Systems. Inc.
Not Provided
Not Provided
SynCardia Systems. Inc.
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP